Safety and Tolerability of the Potassium Binder Patiromer From a Global Pharmacovigilance Database Collected Over 4 Years Compared with Data from the Clinical Trial Program

Introduction The availability of the sodium-free potassium binder patiromer opens new opportunities for hyperkalemia management. Objective Our objective was to compare data from a 4-year global pharmacovigilance database of adverse events (AEs) reported in patients prescribed patiromer in clinical p...

Ausführliche Beschreibung